The interval between frontline treatment and the second relapse (PFS2) predicts survival from the second relapse in follicular lymphoma patients
Sign Up to like & getrecommendations! Published in 2020 at "European Journal of Haematology"
DOI: 10.1111/ejh.13556
Abstract: Follicular lymphoma (FL) is the most frequent indolent B-cell lymphoma. The introduction of immunotherapy has greatly improved outcomes for FL patients, with a median overall survival (OS) now approaching 20 years. However, relapses are continuously… read more here.
Keywords: follicular lymphoma; relapse; frontline treatment; second relapse ... See more keywords